Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Mol Neurobiol (2018) 56:4086101
Key Takeaways: PRP as a First-Line Injection for Knee Osteoarthritis Stronger and longer-lasting pain relief than HA and corticosteroid injections Reduces inflammation and promotes cartilage repair , rather than just masking symptoms Potential to slow OA progression , making it a disease-modifying therapy Fewer side effects compared to corticosteroids, which can accelerate cartilage loss with repeated use Given the growing body of high-level clinical evidence , PRP is increasingly being recommended as a first-line regenerative therapy for knee osteoarthritis, offering a biological approach to symptom management and disease modification
We report here the first empirical evidence of a novel small peptide that functions as a bi-specific agonist for both GLP-1R and GIPR in vitro
What monitoring
